Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 11.25 is 33% above its 5-year average of 8.49, around the middle of its 5-year range (0.11–24.53).
As of the fiscal period ended Tuesday, June 30, 2026. 10.77% above its 12-month average of 10.15.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.25.
QUICK RATIO (ACID-TEST)
11.25
QUICK RATIO (ACID-TEST) AVG TTM
10.15
QUICK RATIO (ACID-TEST) AVG 3Y
11.97
QUICK RATIO (ACID-TEST) AVG 5Y
8.49
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.77%
CURRENT VS 3Y AVG
-6.08%
CURRENT VS 5Y AVG
+32.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+235.73%
vs the sector median at left
Market Cap
$5.82M
Quick Ratio (Acid-Test)
2.35
TTM Avg
1.31
3Y Avg
0.84
5Y Avg
0.78
Market Cap
$5.89M
Quick Ratio (Acid-Test)
2.29
TTM Avg
2.06
3Y Avg
2.43
5Y Avg
2.43
Market Cap
$5.92M
Quick Ratio (Acid-Test)
17.15
TTM Avg
11.86
3Y Avg
7.50
5Y Avg
9.06
Market Cap
$5.73M
Quick Ratio (Acid-Test)
119.39
TTM Avg
100.04
3Y Avg
53.35
5Y Avg
40.07
Market Cap
$5.70M
Quick Ratio (Acid-Test)
11.70
TTM Avg
17.23
3Y Avg
23.62
5Y Avg
22.05
Market Cap
$5.63M
Quick Ratio (Acid-Test)
3.88
TTM Avg
2.19
3Y Avg
2.86
5Y Avg
5.66
Market Cap
$6.11M
Quick Ratio (Acid-Test)
2.97
TTM Avg
1.81
3Y Avg
1.20
5Y Avg
3.15
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lucyd, Inc (LUCY) | $5.83M | 11.25 | 10.15 | 11.97 | 8.49 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.82M | 2.35 | 1.31 | 0.84 | 0.78 |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.89M | 2.29 | 2.06 | 2.43 | 2.43 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.92M | 17.15 | 11.86 | 7.50 | 9.06 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.73M | 119.39 | 100.04 | 53.35 | 40.07 |
| enVVeno Medical Corporation (NVNO)vs › | $5.70M | 11.70 | 17.23 | 23.62 | 22.05 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 3.88 | 2.19 | 2.86 | 5.66 |
| Scienture Holdings, Inc. (SCNX)vs › | $6.11M | 2.97 | 1.81 | 1.20 | 3.15 |
| Femasys Inc. (FEMY)vs › | $6.28M | 0.55 | 1.77 | 4.96 | 6.03 |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | 10.60 | 4.75 | 13.37 | 23.75 |
Quick Ratio
11.25
Excludes inventory
Current Ratio
12.06
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 11.25 |
| 2026-03-31 | 6.09 |
| 2025-12-31 | 7.36 |
| 2025-09-30 | 10.13 |
| 2025-06-30 | 15.93 |
| 2025-03-31 | 13.87 |
| 2024-12-31 | 11.40 |
| 2024-09-30 | 15.43 |
| 2024-06-30 | 12.85 |
| 2024-03-31 | 3.61 |
| 2023-12-31 | 7.62 |
| 2023-09-30 | 15.60 |
| 2023-06-30 | 24.53 |
| 2023-03-31 | 7.53 |
| 2022-12-31 | 6.91 |
| 2022-09-30 | 6.44 |
| 2022-06-30 | 0.11 |
| 2022-03-31 | 0.15 |
| 2021-12-31 | 0.60 |
| 2021-09-30 | 0.25 |
| 2021-06-30 | 0.53 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.07 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
